Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • zake1 zake1 Oct 18, 2013 12:10 PM Flag

    From the symposium

    Conclusions
    •LAI was generally safe and well tolerated, and no unexpected adverse events were observed
    •LAI administered once daily is comparable to TOBI® administered twice daily in improving
    lung function, the standard of care in patients with CF chronically infected with Pa
    •Patients maintained on LAI reported significantly greater improvement in their respiratory
    symptoms compared with the TOBI® arm at the end of the treatment period of the study
    •Patients also reported less treatment burden in the LAI arm, which is administered once daily
    •LAI is an effective inhaled aminoglycoside antibiotic in the treatment of chronic Pa bron cho -

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
24.05-0.26(-1.07%)Sep 4 4:00 PMEDT